°ê½Ã°|¤p¤À¤l§ÜÀùÃĪ«¶Ç¿é¨t²Î¡@¥ÎÃħó¬Ù§óºë·Ç
2021-03-15
941
°ê®a½Ã¥Í¬ã¨s°|15¤é¤W¤ÈÁ|¦æ°OªÌ·|¡A«Å¥¬¬ãµo¹Î¶¤ªº¤p¤À¤l§ÜÀùÃĪ«¶Ç¿é¨t²Î¯à¦³®ÄÄâ±aÃĪ«¨ì¸~½F²ÓM¡A¤wÀò¬ü°ê¹«~ÃĪ«ºÞ²z§½¡]FDA¡^®Öã¶i¤J²Ä¤@´Á¤HÅé¸ÕÅç¡C
¾Ú°ê®a½Ã¥Í¬ã¨s°|ºô¯¸®ø®§¡A°ê®a½Ã¥Í¬ã¨s°|¥Í§Þ»PÃĪ«¬ã¨s©Ò·sÃĬãµo¹Î¶¤©ó¸gÀÙ³¡§Þ³N³B¬ì§Þ±M®×¤ä«ù¤U©Ò¬ãµo¤§¤p¤À¤l§ÜÀùÃĪ«¶Ç¿é¨t²ÎDBPR115¡A¹B¥Î¨ã°ê»Ú±M§Qªº§Þ³N¡A¯à¦³®Ä¦aÄâ±a³sµ²¤§ÃĪ«¦Ü¸~½F²ÓM¡A´£¤ÉÀø®Ä¨Ã°§C°Æ§@¥Î¡CDBPR115 ¤p¤À¤l§ÜÀùÃĪ«¾A¦X°ê¤º¥H¤p¤À¤lÃĪ«¬°¥Dªº²£·~¯S©Ê¡A¥B¬°¥«³õº¨£(first-in-class)·sÃÄ¡A¬O±a»â°ê¤º¤p¤À¤lÃĪ«²£·~ÁÚ¦V¥þ·sÃĪ«¶}µoªºÃöÁä§Þ³N¤§¤@¡CDBPR115»P¥«°âÃĪ«CPT-11¬Û¤ñ¡A¶È»Ý20%¥ÎÃĶq§Y¥i¹F¨ì¼Æ¿¹ï¤j¸zª½¸z¤Î¯ØŦ¸~½F¥Íªø¤§§í¨î®ÄªG¡C
DBPR115¸g¦¨¥\§ÞÂà¨Ã§¹¦¨Á{§É«e¸ÕÅç«á¡A©ó2020¦~12¤ë15¤é¦V¬ü°ê¹«~ÃĪ«ºÞ²z§½(FDA)´£¥X¸ÕÅ礤·sÃÄ(Investigational New Drug, IND)¥Ó½Ð¡A¨Ã¶¶§Q©ó2021¦~1¤ë15¤éÀò¬ü°êFDA®Öã¦P·N°õ¦æ²Ä¤@´ÁÁ{§É¸ÕÅç¡A¬°°ê¤º²Ä¤@Ó¥»¤g¬ãµo¤§§ÜÀùÃĪ«¶Ç¿é¨t²Îªº¨ãÅ馨¥\®×¨Ò¡C
¥»§Þ³N¬O¥»¤gºÓ¥H¤p¤À¤l¾á¥ô¾É¼uÀYªº¼Ð¹v©Ê§ÜÀù¤Æ¦Xª«¡A¨ä¥H¤p¤À¤lÓi¤Æ¦Xª«µ²¦X¥«°âªº§Ü¸~½FÃĪ«¡A¹F¨ì¶Ç»¼¨Ã¶°¤¤§ÜÀùÃĪ«¦Ü¸~½F²Õ´ªº¥\¯à¡A¼W¥[¸~½F¤¤§ÜÀùÃĪ«ªº¿@«×¡A´£¤ÉÃĮĥB°§C°Æ§@¥Î¡C¤p¤À¤lÓiÃĪ«¶Ç¿é¨t²Î°£¨ã³Æ¤Wz¤§¯S©Ê¥~¡AÁÙ¥i¼W±j©ÒÄâ±aªºÃĪ«ªº¿ëÃѤ§«H¸¹¡A¥ç¿¼W¶Ç¿é¨t²Î§ä´M«H¸¹ªº¯à¤O¡A¨ÏªvÀø®ÄªG§ó¦n¡C
¬Û¸û©ó¤j¤À¤lªº¶Ç¿é¨t²Î¡A¤p¤À¤lÓi¤Æ¦Xª«»sµ{éw¡A¥B³y¦¨§K¬Ì¤ÏÀ³ªº¾÷²v¤p¡A¬Û¹ï©ó¥Íª«»s¾¯ªºÀu¶Õ§ó¦h¡A¨î±ø¥ó§ó¤Ö¡Cºî¦X¥H¤WÀuÂI¡A¥»¬ãµo¹Î¶¤©ó§Þ³N²¾Âà«á¡A¦@¦P±À°Ê¬ãµo¦¨ªG²£·~¤Æ¥Ñ¼t°Ó©Ó±µ«áÄò·sÃĶ}µo¤u§@¡C¶}µo·sªºÃĪ«¶Ç¿é»P¿ëÃѨt²Î¡A¬OÃĪ«¬ãµo»â°ì¤¤·¥«nªº¤@³¡¤À¡A¦Ó¦¨¥\¦a¬ãµo¦¹ÃĪ«¶Ç¿é¨t²Î¤£¶È¯à¦³®ÄÀ³¥Î©ó¼Ð¹v§ÜÀùÃĪ«¡A¤]¬°ÃĪ«³]p¬ãµo¶}ÅP·sªº³~®|¡A¬°ªvÀø«¯g¯e¯f±a¨Ó·sªºÀÆ¥ú¡C
°ê®a½Ã¥Í¬ã¨s°|¥Í§Þ»PÃĪ«¬ã¨s©Ò¦b·sÃĬãµo¾á¥ô·sÃı´¯Á¤§¤W´å¬ãµo¨¤¦â¡A¨Ã©µÄò¦Ü¤¤´åµo®i¡C¥Ñ©ó·sÃĬãµo®Éµ{ªø¥B©Ò»Ý¸g¶OÃe¤j¡A°ß¦³¹B¥ÎÀu¶Vªº¤W´å·sÃĬãµo¸gÅç¡A¤~¥i«ùÄò±À°Ê¡B²£¥X¦¨ªG¡A¨ó§U°ê¤º«Ø¥ß§¹µ½ªº¾ãÅé·sÃĵo®iÅé¨t¡C¥»§Þ³N¤§pµe©ó¸gÀÙ³¡§Þ³N³B¸É§Upµe¤U°õ¦æ¡A±Ä·sÃÄ»PÃþ·sÃĪº¬ãµoµ¦²¤¡A§Q¥Î¾ã¦X©Ê§Þ³N¶i¦æÃĪ«¶}µo¡A±N¥i´£¨Ñ°ê¤ºµo®i¥Í§Þ»sÃIJ£·~ªº§Þ³N¨Ó·½¡A§ó§Æ±æ¯à³z¹L¨ãµo®i¼ç¤Oªº¬ã¨s¦¨ªG¡A»P°ê¤º¥Í§Þ·~¡A¤@¦P±N¥»¤g¬ãµo¤§¦¨ªG»P²£«~±À¦V°ê»Ú¡C
¡i¹Ï¤ù¨Ó·½¡G¤¤¥¡ªÀ¡]°ê½Ã°|´£¨Ñ¡^¡j
DBPR115¸g¦¨¥\§ÞÂà¨Ã§¹¦¨Á{§É«e¸ÕÅç«á¡A©ó2020¦~12¤ë15¤é¦V¬ü°ê¹«~ÃĪ«ºÞ²z§½(FDA)´£¥X¸ÕÅ礤·sÃÄ(Investigational New Drug, IND)¥Ó½Ð¡A¨Ã¶¶§Q©ó2021¦~1¤ë15¤éÀò¬ü°êFDA®Öã¦P·N°õ¦æ²Ä¤@´ÁÁ{§É¸ÕÅç¡A¬°°ê¤º²Ä¤@Ó¥»¤g¬ãµo¤§§ÜÀùÃĪ«¶Ç¿é¨t²Îªº¨ãÅ馨¥\®×¨Ò¡C
¥»§Þ³N¬O¥»¤gºÓ¥H¤p¤À¤l¾á¥ô¾É¼uÀYªº¼Ð¹v©Ê§ÜÀù¤Æ¦Xª«¡A¨ä¥H¤p¤À¤lÓi¤Æ¦Xª«µ²¦X¥«°âªº§Ü¸~½FÃĪ«¡A¹F¨ì¶Ç»¼¨Ã¶°¤¤§ÜÀùÃĪ«¦Ü¸~½F²Õ´ªº¥\¯à¡A¼W¥[¸~½F¤¤§ÜÀùÃĪ«ªº¿@«×¡A´£¤ÉÃĮĥB°§C°Æ§@¥Î¡C¤p¤À¤lÓiÃĪ«¶Ç¿é¨t²Î°£¨ã³Æ¤Wz¤§¯S©Ê¥~¡AÁÙ¥i¼W±j©ÒÄâ±aªºÃĪ«ªº¿ëÃѤ§«H¸¹¡A¥ç¿¼W¶Ç¿é¨t²Î§ä´M«H¸¹ªº¯à¤O¡A¨ÏªvÀø®ÄªG§ó¦n¡C
¬Û¸û©ó¤j¤À¤lªº¶Ç¿é¨t²Î¡A¤p¤À¤lÓi¤Æ¦Xª«»sµ{éw¡A¥B³y¦¨§K¬Ì¤ÏÀ³ªº¾÷²v¤p¡A¬Û¹ï©ó¥Íª«»s¾¯ªºÀu¶Õ§ó¦h¡A¨î±ø¥ó§ó¤Ö¡Cºî¦X¥H¤WÀuÂI¡A¥»¬ãµo¹Î¶¤©ó§Þ³N²¾Âà«á¡A¦@¦P±À°Ê¬ãµo¦¨ªG²£·~¤Æ¥Ñ¼t°Ó©Ó±µ«áÄò·sÃĶ}µo¤u§@¡C¶}µo·sªºÃĪ«¶Ç¿é»P¿ëÃѨt²Î¡A¬OÃĪ«¬ãµo»â°ì¤¤·¥«nªº¤@³¡¤À¡A¦Ó¦¨¥\¦a¬ãµo¦¹ÃĪ«¶Ç¿é¨t²Î¤£¶È¯à¦³®ÄÀ³¥Î©ó¼Ð¹v§ÜÀùÃĪ«¡A¤]¬°ÃĪ«³]p¬ãµo¶}ÅP·sªº³~®|¡A¬°ªvÀø«¯g¯e¯f±a¨Ó·sªºÀÆ¥ú¡C
°ê®a½Ã¥Í¬ã¨s°|¥Í§Þ»PÃĪ«¬ã¨s©Ò¦b·sÃĬãµo¾á¥ô·sÃı´¯Á¤§¤W´å¬ãµo¨¤¦â¡A¨Ã©µÄò¦Ü¤¤´åµo®i¡C¥Ñ©ó·sÃĬãµo®Éµ{ªø¥B©Ò»Ý¸g¶OÃe¤j¡A°ß¦³¹B¥ÎÀu¶Vªº¤W´å·sÃĬãµo¸gÅç¡A¤~¥i«ùÄò±À°Ê¡B²£¥X¦¨ªG¡A¨ó§U°ê¤º«Ø¥ß§¹µ½ªº¾ãÅé·sÃĵo®iÅé¨t¡C¥»§Þ³N¤§pµe©ó¸gÀÙ³¡§Þ³N³B¸É§Upµe¤U°õ¦æ¡A±Ä·sÃÄ»PÃþ·sÃĪº¬ãµoµ¦²¤¡A§Q¥Î¾ã¦X©Ê§Þ³N¶i¦æÃĪ«¶}µo¡A±N¥i´£¨Ñ°ê¤ºµo®i¥Í§Þ»sÃIJ£·~ªº§Þ³N¨Ó·½¡A§ó§Æ±æ¯à³z¹L¨ãµo®i¼ç¤Oªº¬ã¨s¦¨ªG¡A»P°ê¤º¥Í§Þ·~¡A¤@¦P±N¥»¤g¬ãµo¤§¦¨ªG»P²£«~±À¦V°ê»Ú¡C
¡i¹Ï¤ù¨Ó·½¡G¤¤¥¡ªÀ¡]°ê½Ã°|´£¨Ñ¡^¡j
§@ªÌ¤¶²Ð
©µ¦ù¾\Ū